Connect your AI

Bristol-Myers Squibb BMY Gross Profit

Gross Profit at other companies

PfizerPFE

$10.9B+0.3%

Johnson & JohnsonJNJ

$15.96B+9.8%

Merck & Co.MRK

$12.09B-0.2%

Gilead SciencesGILD

$5.52B+7.6%

IncyteINCY

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

Revenue$11.5B+2.6%

Net income$2.7B+9.0%

EPS (diluted)$1.31+9.2%

Balance sheet

Cash & equivalents$9.6B-12.0%

Total debt$44.7B-10.5%

Total equity$20.1B+15.4%

Total assets$86.5B-6.4%

Cash flow

Operating cash flow$1.1B-43.5%

CapEx$347.0M+33.5%

Free cash flow$757.0M-55.3%

Valuation

Market cap$113.11B+18.6%

Enterprise value$148.2B+10.3%

P/E15.6×-2.3×

P/S2.3×+0.3×

Profitability

Gross margin70.5%0.0pp

Net margin15%+3.8pp

FCF margin24.6%-2.9pp

Returns & leverage

Return on equity38.8%+7.3pp

Debt / equity2.2×-0.6×

Current ratio1.4×+0.1×

Where this comes from

Calculated from Bristol-Myers Squibb’s reported figures.

$11.5Btotal revenue−$3.4Btotal cost of revenue=$8.07B

The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bristol-Myers Squibb's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Bristol-Myers Squibb's gross profit?: Bristol-Myers Squibb (BMY) reported gross profit of $8.07B in Q1 2026.
How has Bristol-Myers Squibb's gross profit changed year-over-year?: Bristol-Myers Squibb's gross profit decreased by 1.2% year-over-year, from $8.17B to $8.07B.
What is the long-term trend for Bristol-Myers Squibb's gross profit?: Over 4 years (2021 to 2025), Bristol-Myers Squibb's gross profit has grown at a -1.5% compound annual growth rate (CAGR), from $36.45B to $34.26B.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.